New FTC Pharma Patent Litigation Report Finds Increase in "Reverse Payment" Settlements Based on Expanded Definition of "Payments"
Michael H. Knight,Kevin D. McDonald,Phillip A. Proger,Michael Sennett,Pamela L. Taylor, February 8, 2013
With the Supreme Court set to address the validity of "reverse payment" settlements of pharmaceutical patent litigation, the FTC released a summary of its new report, announcing that in 2012 drug companies entered "a record number" of such settlements. However, the underlying...